title: Inclusion and recommendation of (1→3)-β-D-glucan testing in the international guidelines for management of severe sepsis and septic shock.
authors.affiliation: Department of Pharmacy Services, University of Arizona Medical Center; and Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson, AZ; Department of Pharmacy Services, University of Arizona Medical Center; and Section of Hematology/Oncology, Arizona Cancer Center, Tucson, AZ.
authors.forename: Velliyur V
authors.initials: VV
authors.lastname: Viswesh
authors.forename: John J
authors.initials: JJ
authors.lastname: Radosevich
authors.forename: Myke R
authors.initials: MR
authors.lastname: Green
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D003422:Critical Care; D005260:Female; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D006493:Heparin